Cargando…
Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy
PURPOSE: The purpose of this study was to define the role of cyclooxygenase-2 inhibitors (COX-2i) in reducing hepatic fibrosis in pediatric patients with chronic liver disease. MATERIALS AND METHODS: From September 2009 to September 2010, patients over 2 years old who visited our outpatient clinic f...
Autores principales: | Chang, Hye Kyung, Chang, Eun Young, Ryu, Seonae, Han, Seok Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951465/ https://www.ncbi.nlm.nih.gov/pubmed/27189282 http://dx.doi.org/10.3349/ymj.2016.57.4.893 |
Ejemplares similares
-
Home intravenous antibiotic treatment for intractable cholangitis in patients with biliary atresia following Kasai portoenterostomies
por: Shin, Jae Ho, et al.
Publicado: (2011) -
Choice of Prophylactic Antibiotic Post Kasai Portoenterostomy
por: Redkar, Rajeev, et al.
Publicado: (2020) -
The Development of an Enhanced Recovery Protocol for Kasai Portoenterostomy
por: Vogt, Peggy, et al.
Publicado: (2022) -
Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy
por: Tyraskis, Athanasios, et al.
Publicado: (2015) -
Relevant factors for early liver transplantation after Kasai portoenterostomy
por: Ge, Liang, et al.
Publicado: (2020)